The dates for the 2026 Florida Python Challenge are set. Here's how last year's winner captured a whopping 60 pythons for the $10,000 grand prize.

Actor David Hasselhoff was spotted utilizing a walker during a public outing, an appearance representatives clarified is due to the actor recovering from knee and hip replacement surgeries. The ...

Codex Desktop expands from coding into full productivity workflows. Automation can generate images, charts, and workflow outputs. The tool is still aimed at developers despite the broader productivity ...

What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...

As the snow melts, the ground thaws and trails in my corner of the Pacific Northwest emerge from hibernation, I look forward to that quiet Sunday afternoon spent rooting through my closet to resurface ...

Florida's Python Elimination Program pays certified hunters to remove the invasive snakes from the Everglades. Burmese pythons have caused a severe decline in native small mammal populations in South ...

With the writing on the wall as it concerns Ken Walker’s upcoming free agency and Zach Charbonnet likely on ice for much of 2026, here are my ideas. The Seahawks need a complete overhaul in the ...

Anthropic (ANTHRO) is on track to generate nearly $20B in annual revenue, more than doubling its run rate from $9B at the end of 2025, driven by strong adoption of its AI models and products such as ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

The ruling by the Oregon Land Use Board of Appeals favors the city’s plans to build a plant to filter water from the forested watershed. A demonstration of operations at a pilot water treatment plant, ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.